Skip to main content
FinSpry Logo
FinSpry
SPRO logo
SPRO
(NASDAQ)
Spero Therapeutics, Inc.
$2.63-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Spero Therapeutics (SPRO) Stock Price & Financial Analysis

Spero Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.55 - $2.65
52-Week High$3.22
52-Week Low$0.61
Open$2.59
Volume319.55K
Average Volume (3M)533.40K
Market Cap153.76M
Shares Outstanding59.37M
P/E Ratio (TTM)17.94
Price to Sales (P/S)2.55
Price to Book (P/B)2.61
EV/EBITDA16.67
Revenue (TTM)60.38M
Net Income (TTM)8.57M
Free Cash Flow (TTM)-12.62M
EPS (TTM)$0.15
Profit Margin14.20%
Operating Margin11.57%
Return on Equity (ROE)14.52%
Debt to Equity0.05
50-Day MA$2.54
200-Day MA$2.32
52-Week Change318.03%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Spero Therapeutics

What is the current stock price for SPRO?

As of the latest trading session, SPRO stock trades at $2.63. The 52-week range is $0.61–$3.22, with a day range of $2.55–$2.65.

What is the P/E ratio for SPRO?

Spero Therapeutics's trailing P/E ratio is 17.9, meaning investors pay $17.9 for every $1 of annual earnings.

Does SPRO pay dividends?

Spero Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SPRO?

Analyst ratings and recommendations for SPRO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of SPRO?

Spero Therapeutics's market capitalization is $156.1M, classifying it as a micro-cap company..